Find uplifting stories about heroes, innovations, and solutions
2362 results for "childhood epilepsy"
Children with a devastating form of epilepsy may soon have new hope thanks to promising trial results from an experimental treatment. Praxis Precision Medicines announced their drug elsunersen successfully reduced seizures in early testing for SCN2A-related epilepsy.
Scientists discovered that brain inflammation drives Dravet syndrome, a devastating form of childhood epilepsy, opening the door to treatments that could help thousands of children. By blocking a specific immune pathway, researchers reduced seizures in early studies.
Scientists in Jerusalem discovered a tiny peptide that not only reduces seizures but protects brain cells from long-term damage in treatment-resistant epilepsy. For the 40% of epilepsy patients who don't respond well to current medications, this breakthrough offers new hope.
Childhood Cancer International's survivor network, SurNet, brought together childhood cancer survivors worldwide in 2025 through webinars, shared stories, and advocacy. The growing community is now expanding partnerships to reach even more survivors seeking connection and hope.
St. Jude Children's Research Hospital's new CEO says a "once-in-a-lifetime" breakthrough moment is happening right now in childhood cancer treatment. Survival rates have soared from 20% to over 80% since 1962, and the goal of making all childhood cancers easily treatable is closer than ever.
French researchers have pinpointed the exact brain cells that store early childhood scent memories, explaining why a simple smell can transport you back decades. The discovery reveals that special cells formed on day one of life capture our first pleasant experiences.
When two-year-old Briar Curtis's heart stopped for two minutes during a seizure, a tiny implanted monitor caught it—thanks to research that discovered a surprising link between epilepsy and deadly heart problems. Now she's thriving in preschool with energy her mom never thought possible.
A groundbreaking drug called zorevunersen slashed seizures by up to 91% in children with Dravet syndrome, a devastating form of epilepsy that causes developmental delays and sudden death. Unlike other treatments, this drug tackles the genetic root cause and could change the course of the disease.
A breakthrough treatment for seizure disorders exceeded expectations in its final clinical trial, bringing hope to millions who live with epilepsy. The drug reduced seizure frequency significantly and could reach patients by late 2026.
A new Senate inquiry into epilepsy in Australia offers hope to thousands of families struggling with funding gaps for care and support services. Four-year-old Leo's family is among those waiting for changes that could make life-saving assistance more accessible.
A breakthrough medication helped highly treatment-resistant epilepsy patients reduce their seizures by more than half in a major clinical trial. The once-daily pill works through an entirely new mechanism and could reach patients by next year.
University of Virginia researchers used gene editing to fix the DNA mutation causing a deadly form of epilepsy, potentially opening the door to cures for inherited brain disorders. The technique eliminated seizures in lab mice and improved their movement and cognitive function.
Two boys with severe epilepsy are living seizure-reduced lives after receiving personalized gene therapy that targeted their unique brain abnormalities. The treatment also improved their developmental skills, offering new hope for families facing debilitating neurological disorders.
A new biotech company just launched with $106 million to bring promising brain disorder treatments to Americans. Tortugas Neuroscience is testing four drugs for conditions that affect millions, including schizophrenia, tinnitus, and epilepsy.
Scientists discovered that calming an overactive immune pathway in the brain reduces seizures in mice with Dravet syndrome, a severe form of childhood epilepsy. The breakthrough could lead to new treatments for the one-third of epilepsy patients who don't respond to current medications.
An Australian baby became the first person in the world to receive a precision medicine treatment for a rare, often-fatal form of epilepsy. Three days after his first dose, eight-month-old Bohdi Higginson had his final seizure.
A breakthrough treatment is transforming lives for children with Dravet syndrome, a severe form of epilepsy that can cause hundreds of seizures daily. Eight-year-old Freddie Truelove went from constant fits to just two seizures a week and is now skiing and climbing mountains.
New research shows that strong parental relationships in adulthood can actually shift how young people remember difficult childhoods. The discovery could transform how doctors and researchers understand trauma and healing.
A growing movement of parents is bringing back bike rides, boredom, and face-to-face play as concerns mount over excessive screen time replacing childhood experiences. The interim U.S. Surgeon General is backing their efforts with practical guidance for families.
Scientists discovered that revisiting painful childhood memories through imagery therapy can reduce fear of failure for months. Young adults who imagined supportive endings to distressing experiences showed lasting drops in fear, guilt, and stress.
Showing 20 of 2362